<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04722445</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A01690-39</org_study_id>
    <nct_id>NCT04722445</nct_id>
  </id_info>
  <brief_title>Ultrasound Measurement of Quadriceps Shortening During Neuromuscular Electrical Stimulation in Critically Ill Patients</brief_title>
  <acronym>DETECT</acronym>
  <official_title>Diagnostic Accuracy of Early ulTrasound Measurement of Quadriceps Thickness During Neuromuscular EleCTrical Stimulation for the Diagnosis of ICU-acquired Weakness : an Observational Study (DETECT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier du Havre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier du Havre</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      ICU-Aw is highly prevalent (50%) among critically ill patients. Its diagnosis is usually&#xD;
      delayed as it requires patients' awakening and collaboration to provide accurate measurement.&#xD;
&#xD;
      This study aims to investigate the accuracy of an early ultrasound measurement of quadriceps&#xD;
      shortening during neuromuscular electrical stimulation to diagnose future ICU-Aw in&#xD;
      critically ill patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 16, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 16, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ICU-Aw diagnosis</measure>
    <time_frame>In the 24 hours following extubation</time_frame>
    <description>Measured with the Medical Research Council score (scored 0 (minimum) to 60 (maximum); with a score &lt; 48 meaning ICU-acquired weakness)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Respiratory muscles strength</measure>
    <time_frame>In the 30 minutes before extubation (during spontaneous breathing trial)</time_frame>
    <description>Maximal Inspiratory Pressure and Maximal Expiratory Pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cough capacity</measure>
    <time_frame>In the 30 minutes before extubation (during spontaneous breathing trial)</time_frame>
    <description>Peak Cough Flow</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extubation failure/success</measure>
    <time_frame>Within 48 hours after extubation</time_frame>
    <description>Reintubation or death</description>
  </secondary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>ICU Acquired Weakness</condition>
  <condition>Quadriceps Muscle Atrophy</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Early ultrasound measurement of quadriceps shortening during neuromuscular electrical stimulation (NMES)</intervention_name>
    <description>NMES will be applied to the quadriceps muscle to generate muscle contraction. Ultrasound measurement of the quadriceps thickness will be provided during contraction and rest, and the shortening of the quadriceps muscle will be measured. A second measurement using Shear-wave elastography measurement will also be undertaken. The measures will be undertaken at day 1 of neuromuscular blockers liberation (if any) as well as at day 3 and day 7 for the patients that will still be received mechanical ventilation at that time.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill patients admitted in ICU departement and mechanically ventilated for at&#xD;
        least 24 hours without counterindications to provide NMES.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Mechanical ventilation for at least 24 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Decision to withhold life-sustaining treatment&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Degenerative neurological pathology with disabling muscle weakness&#xD;
&#xD;
          -  Pace Maker&#xD;
&#xD;
          -  Inability to communicate&#xD;
&#xD;
          -  Chronic loss of autonomy described by the patient's family&#xD;
&#xD;
          -  Guardianship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yann Combret, PhD, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier du Havre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yann Combret, PhD, PT</last_name>
    <phone>+33786952577</phone>
    <email>yann.combret@ch-havre.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Groupe Hospitalier du Havre</name>
      <address>
        <city>Montivilliers</city>
        <zip>76290</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yann Combret, PhD, PT</last_name>
      <phone>+33786952577</phone>
      <email>yann.combret@ch-havre.fr</email>
    </contact>
    <investigator>
      <last_name>Yann Combret, PhD, PT</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume Prieur, PhD, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cl√©ment Medrinal, PhD, PT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Medrinal C, Combret Y, Hilfiker R, Prieur G, Aroichane N, Gravier FE, Bonnevie T, Contal O, Lamia B. ICU outcomes can be predicted by noninvasive muscle evaluation: a meta-analysis. Eur Respir J. 2020 Oct 1;56(4). pii: 1902482. doi: 10.1183/13993003.02482-2019. Print 2020 Oct.</citation>
    <PMID>32366493</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

